(Q36144375)

12 August 2017

1 reference

title

IBS and IBD - separate entities or on a spectrum? (English)

1 reference

12 August 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Robin Spiller

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

1 September 2016

1 reference

Nature Reviews Gastroenterology & Hepatology

12 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

613-621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27667579%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2016.141

1 June 2020

exact match

0 references

cites work

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

A prospective population-based study of triggers of symptomatic flares in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

New insights into IBD epidemiology: Are there any lessons for treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Local and systemic liberation of proinflammatory cytokines in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Psychological stress activates interleukin-1beta gene expression in human mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Heightened responses to stressors in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Genetics and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Infectious gastroenteritis and risk of developing inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chromogranin A cell density as a diagnostic marker for lymphocytic colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Dental neuroplasticity, neuro-pulpal interactions, and nerve regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Post-inflammatory colonic afferent sensitisation: different subtypes, different pathways and different time courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Neurochemical coding in the small intestine of patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Substance P containing nerve fibers in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Dietary intake of inulin-type fructans in active and inactive Crohn's disease and healthy controls: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Association of TNFSF15 polymorphism with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The epidemiology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Perceptual responses in patients with inflammatory and functional bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Limited exposure of the healthy distal colon to orally-dosed formulation is further exaggerated in active left-sided ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The role of serotonin in intestinal luminal sensing and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Luminally released serotonin stimulates colonic motility and accelerates colonic transit in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Role of serotonin 5-HT₃ receptors in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Irritable bowel syndrome: psychology, biology, and warfare between false dichotomies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Plasma chromogranin a in patients with inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The neurochemical changes in the innervation of human colonic mesenteric and submucosal blood vessels in ulcerative colitis and Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.141

The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases

31 March 2020

1 reference

12 December 2020

Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission.

1 reference

12 December 2020

Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?

1 reference

12 December 2020

Intestinal permeability assessed with polyethylene glycols in children with diarrhea due to rotavirus and common bacterial pathogens in a developing community.

1 reference

12 December 2020

Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review

1 reference

12 December 2020

Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study

1 reference

12 December 2020